EPINASTINE HYDROCHLORIDE

EPINASTINE HYDROCHLORIDE was reported 1140 times

EPINASTINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VESSEL PUNCTURE SITE INFECTION 2 0.4000
1 ALLERGIC CYSTITIS 2 0.2500
2 GASTRODUODENAL ARTERY ANEURYSM 1 0.1667
3 MAZZOTTI REACTION 1 0.0909
4 GAMING DISORDER 1 0.0526
5 EYE IRRIGATION 1 0.0455
6 LEFT VENTRICULAR END-DIASTOLIC PRESSURE DECREASED 1 0.0435
7 NOCARDIA TEST POSITIVE 1 0.0385
8 OROPHARYNGEAL GONOCOCCAL INFECTION 1 0.0370
9 ENZYME LEVEL ABNORMAL 5 0.0357
10 COMPENSATORY SWEATING 1 0.0357
11 MENINGITIS NONINFECTIVE 2 0.0317
12 CARDIOTHORACIC RATIO INCREASED 2 0.0317
13 CHRONIC EOSINOPHILIC RHINOSINUSITIS 1 0.0294
14 HYPOLIPIDAEMIA 1 0.0263
15 FACTOR IX INHIBITION 3 0.0242
16 CALCULUS PROSTATIC 1 0.0222
17 ANALGESIC ASTHMA SYNDROME 1 0.0154
18 ALOPECIA TOTALIS 5 0.0152
19 FIBROUS DYSPLASIA OF BONE 1 0.0135
20 MIXED DEAFNESS 1 0.0127
21 HISTIOCYTIC NECROTISING LYMPHADENITIS 1 0.0115
22 BLOOD CREATINE PHOSPHOKINASE DECREASED 3 0.0091
23 AMYLASE DECREASED 1 0.0090
24 FOREIGN BODY INGESTION 1 0.0089
25 ASTEATOSIS 1 0.0085
26 ANTIBIOTIC RESISTANT STAPHYLOCOCCUS TEST POSITIVE 1 0.0084
27 INCARCERATED INGUINAL HERNIA 1 0.0082
28 ITCHING SCAR 1 0.0078
29 MALIGNANT NEOPLASM OF RENAL PELVIS 1 0.0073
30 DUODENITIS HAEMORRHAGIC 1 0.0072
31 BETA 2 MICROGLOBULIN URINE INCREASED 1 0.0070
32 BLOOD CORTICOTROPHIN INCREASED 2 0.0069
33 ALOPECIA UNIVERSALIS 2 0.0068
34 CEREBROVASCULAR STENOSIS 1 0.0068
35 NEUROFIBROMA 1 0.0067
36 NEUROSYPHILIS 1 0.0066
37 COSTOVERTEBRAL ANGLE TENDERNESS 1 0.0061
38 VASCULAR DEVICE OCCLUSION 2 0.0059
39 LARGE INTESTINE CARCINOMA 1 0.0054
40 KIDNEY RUPTURE 1 0.0054
41 CYSTITIS RADIATION 1 0.0052
42 ALOPECIA AREATA 9 0.0051
43 DEAFNESS PERMANENT 1 0.0051
44 ACUTE CHOLECYSTITIS NECROTIC 1 0.0050
45 LENS DISLOCATION 1 0.0048
46 BRAIN NATRIURETIC PEPTIDE ABNORMAL 1 0.0047
47 KL-6 INCREASED 1 0.0044
48 ORAL PUSTULE 1 0.0043
49 HAEMOPHILIC ARTHROPATHY 1 0.0042
50 CELL MARKER INCREASED 2 0.0042
51 UPPER RESPIRATORY TRACT INFLAMMATION 5 0.0042
52 CORNEAL DEGENERATION 1 0.0041
53 TREATMENT FAILURE 317 0.0038
54 B-LYMPHOCYTE COUNT DECREASED 5 0.0037
55 ANTITHROMBIN III DECREASED 1 0.0037
56 ENTEROCOLITIS BACTERIAL 1 0.0036
57 COLON CANCER RECURRENT 1 0.0036
58 CARBUNCLE 1 0.0035
59 NON-SMALL CELL LUNG CANCER RECURRENT 1 0.0035
60 BIOPSY KIDNEY 1 0.0035
61 ENGRAFT FAILURE 1 0.0035
62 BACTERIAL VULVOVAGINITIS 1 0.0035
63 ERYTHEMA ANNULARE 1 0.0034
64 GENERALISED PUSTULAR PSORIASIS 1 0.0034
65 ENGRAFTMENT SYNDROME 2 0.0034
66 STOMA SITE HYPERGRANULATION 2 0.0032
67 LOSS OF PROPRIOCEPTION 1 0.0031
68 CANDIDA PNEUMONIA 1 0.0031
69 CHONDROCALCINOSIS 2 0.0031
70 JUVENILE ARTHRITIS 1 0.0030
71 ENDOMETRITIS 2 0.0030
72 CORONAVIRUS TEST POSITIVE 3 0.0029
73 FIBROUS HISTIOCYTOMA 1 0.0028
74 GALLBLADDER ENLARGEMENT 3 0.0028
75 ALANINE AMINOTRANSFERASE DECREASED 2 0.0028
76 SYPHILIS 2 0.0028
77 MIXED ANXIETY AND DEPRESSIVE DISORDER 1 0.0027
78 KERATOCONUS 1 0.0027
79 CYTOMEGALOVIRUS ENTEROCOLITIS 2 0.0026
80 LYMPHOCYTE STIMULATION TEST POSITIVE 2 0.0025
81 SYNCOPE VASOVAGAL 2 0.0024
82 GASTROINTESTINAL CANDIDIASIS 1 0.0024
83 MIXED CONNECTIVE TISSUE DISEASE 1 0.0024
84 SUBCUTANEOUS HAEMATOMA 3 0.0023
85 GASTROINTESTINAL HYPERMOTILITY 1 0.0023
86 HYPOPITUITARISM 4 0.0023
87 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 2 0.0023
88 ANAEMIA MEGALOBLASTIC 1 0.0022
89 LYMPHOCYTE PERCENTAGE DECREASED 3 0.0022
90 ECZEMA HERPETICUM 1 0.0022
91 GALLBLADDER RUPTURE 1 0.0022
92 PROTHROMBIN LEVEL DECREASED 2 0.0021
93 ANTINUCLEAR ANTIBODY INCREASED 2 0.0021
94 RENAL INFARCT 3 0.0021
95 BLOOD CORTICOTROPHIN DECREASED 1 0.0020
96 ARTERIOVENOUS FISTULA 1 0.0020
97 HYPERCALCIURIA 1 0.0020
98 ENCEPHALITIS HERPES 1 0.0020
99 CONJUNCTIVITIS ALLERGIC 3 0.0020
100 ASPARTATE AMINOTRANSFERASE DECREASED 1 0.0019
101 MEDICAL DEVICE CHANGE 1 0.0019
102 COATING IN MOUTH 1 0.0019
103 BRONCHOSTENOSIS 1 0.0018
104 GASTROENTERITIS ESCHERICHIA COLI 1 0.0018
105 PNEUMONIA STREPTOCOCCAL 2 0.0018
106 CARDIAC HYPERTROPHY 2 0.0018
107 MEDICAL DEVICE SITE PAIN 1 0.0018
108 APNOEIC ATTACK 1 0.0018
109 BACTERIURIA 1 0.0018
110 COLLAGEN DISORDER 1 0.0017
111 LYMPHOCYTE MORPHOLOGY ABNORMAL 1 0.0017
112 HYPERURICAEMIA 7 0.0017
113 CYTOMEGALOVIRUS TEST POSITIVE 3 0.0017
114 CERVICOBRACHIAL SYNDROME 1 0.0016
115 MUSCLE ABSCESS 1 0.0016
116 CORTISOL INCREASED 1 0.0016
117 NEUTROPHIL PERCENTAGE INCREASED 2 0.0016
118 EPSTEIN-BARR VIRUS TEST POSITIVE 1 0.0016
119 GASTROINTESTINAL EROSION 1 0.0016
120 PANCREATIC CARCINOMA STAGE II 1 0.0016
121 KLEBSIELLA TEST POSITIVE 1 0.0015
122 INJECTION SITE EXFOLIATION 1 0.0015
123 DEFAECATION DISORDER 1 0.0015
124 ABSCESS NECK 1 0.0015
125 DRUG ERUPTION 26 0.0015
126 CORNEAL OPACITY 2 0.0015
127 KERATOACANTHOMA 1 0.0015
128 CYTOKINE STORM 1 0.0015
129 AORTITIS 1 0.0015
130 COMPUTERISED TOMOGRAM THORAX ABNORMAL 1 0.0015
131 ANGULAR CHEILITIS 1 0.0014
132 PROTHROMBIN TIME SHORTENED 2 0.0014
133 FUNGAL OESOPHAGITIS 1 0.0014
134 CONNECTIVE TISSUE DISORDER 2 0.0014
135 RADIATION PNEUMONITIS 3 0.0014
136 LIPIDS ABNORMAL 1 0.0014
137 DYSLALIA 1 0.0014
138 BLOOD BILIRUBIN UNCONJUGATED INCREASED 1 0.0014
139 DYSLIPIDAEMIA 7 0.0014
140 CYCLIC VOMITING SYNDROME 1 0.0014
141 BRAIN CONTUSION 1 0.0014
142 CLONIC CONVULSION 1 0.0014
143 STOMA SITE PAIN 2 0.0014
144 COMA HEPATIC 1 0.0013
145 PSEUDOMEMBRANOUS COLITIS 3 0.0013
146 GINGIVAL ABSCESS 1 0.0013
147 CHLAMYDIAL INFECTION 1 0.0013
148 OVARIAN NEOPLASM 1 0.0013
149 CONTRAINDICATION TO MEDICAL TREATMENT 2 0.0013
150 MALIGNANT ASCITES 1 0.0013
151 BRAIN NATRIURETIC PEPTIDE INCREASED 4 0.0013
152 METAPNEUMOVIRUS INFECTION 1 0.0013
153 EXTRADURAL ABSCESS 1 0.0013
154 CHRONIC HEPATITIS 1 0.0012
155 MYCOTIC ALLERGY 1 0.0012
156 ALLERGIC SINUSITIS 1 0.0012
157 CHOREA 2 0.0012
158 BREAST CYST 2 0.0011
159 CANDIDA SEPSIS 1 0.0011
160 BLOOD ALKALINE PHOSPHATASE ABNORMAL 1 0.0011
161 OROPHARYNGEAL CANDIDIASIS 1 0.0011
162 MEAN CELL HAEMOGLOBIN DECREASED 2 0.0011
163 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 3 0.0011
164 STOMA SITE ERYTHEMA 2 0.0011
165 INFUSION SITE NODULE 1 0.0010
166 ENTEROCOLITIS 6 0.0010
167 EPIDERMAL NECROSIS 1 0.0010
168 ADRENOCORTICAL INSUFFICIENCY ACUTE 2 0.0010
169 EOSINOPHILIC PNEUMONIA 3 0.0010
170 OEDEMA MUCOSAL 1 0.0010
171 BILE DUCT STONE 3 0.0009
172 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 1 0.0009
173 AMAUROSIS FUGAX 1 0.0009
174 PEMPHIGOID 7 0.0009
175 PERIODONTITIS 2 0.0009
176 INFUSION SITE MASS 1 0.0009
177 DIABETIC NEPHROPATHY 2 0.0009
178 NEPHRITIS 3 0.0009
179 LARGE INTESTINAL HAEMORRHAGE 2 0.0009
180 BLOOD LACTATE DEHYDROGENASE INCREASED 14 0.0009
181 CORTISOL DECREASED 1 0.0009
182 CARBON DIOXIDE DECREASED 1 0.0009
183 HAEMOLYTIC URAEMIC SYNDROME 2 0.0009
184 HEPATIC FUNCTION ABNORMAL 32 0.0009
185 GLOMERULONEPHRITIS MEMBRANOUS 1 0.0009
186 CHRONIC GRAFT VERSUS HOST DISEASE 3 0.0008
187 CHRONIC RESPIRATORY FAILURE 1 0.0008
188 ENCEPHALITIS VIRAL 1 0.0008
189 DERMATITIS ACNEIFORM 5 0.0008
190 FEBRILE CONVULSION 1 0.0008
191 MONOCYTE COUNT DECREASED 1 0.0008
192 CHOLANGITIS 5 0.0008
193 DERMATITIS EXFOLIATIVE 4 0.0008
194 GLUCOSE URINE PRESENT 1 0.0008
195 NOCTURNAL DYSPNOEA 1 0.0008
196 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 1 0.0008
197 BLOOD BILIRUBIN ABNORMAL 1 0.0008
198 LUNG OPACITY 2 0.0008
199 BLOOD PHOSPHORUS INCREASED 2 0.0007
200 MUCOUS MEMBRANE DISORDER 1 0.0007
201 SUBDURAL HAEMORRHAGE 2 0.0007
202 STOMA SITE DISCHARGE 2 0.0007
203 MENINGITIS VIRAL 1 0.0007
204 NEPHROTIC SYNDROME 5 0.0007
205 RED CELL DISTRIBUTION WIDTH INCREASED 3 0.0007
206 GASTROINTESTINAL PERFORATION 3 0.0007
207 DISCHARGE 1 0.0007
208 ECHOCARDIOGRAM ABNORMAL 1 0.0007
209 RENAL TUBULAR DISORDER 2 0.0007
210 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 1 0.0007
211 AUDITORY DISORDER 1 0.0007
212 MENINGITIS BACTERIAL 1 0.0007
213 BLOOD URIC ACID INCREASED 4 0.0007
214 RHINITIS ALLERGIC 3 0.0007
215 HISTIOCYTOSIS HAEMATOPHAGIC 2 0.0007
216 PLEURISY 4 0.0007
217 CHOLANGIOCARCINOMA 1 0.0007
218 GASTRITIS HAEMORRHAGIC 1 0.0007
219 MYELOFIBROSIS 2 0.0007
220 MARASMUS 1 0.0007
221 INFECTIOUS PLEURAL EFFUSION 1 0.0007
222 MYOGLOBIN BLOOD INCREASED 1 0.0007
223 BLOOD PRESSURE IMMEASURABLE 1 0.0007
224 CALCULUS URINARY 1 0.0006
225 MEAN CELL VOLUME DECREASED 1 0.0006
226 EPSTEIN-BARR VIRUS INFECTION 4 0.0006
227 INTERMITTENT CLAUDICATION 1 0.0006
228 POLYMYALGIA RHEUMATICA 2 0.0006
229 OPTIC NERVE DISORDER 1 0.0006
230 CYSTITIS INTERSTITIAL 1 0.0006
231 SKIN EROSION 2 0.0006
232 OXYGEN THERAPY 1 0.0006
233 EDUCATIONAL PROBLEM 1 0.0006
234 EOSINOPHIL COUNT INCREASED 5 0.0006
235 TOXIC SKIN ERUPTION 6 0.0006
236 ENTERITIS INFECTIOUS 1 0.0006
237 FEMORAL NECK FRACTURE 3 0.0006
238 PUSTULAR PSORIASIS 2 0.0006
239 MICTURITION DISORDER 2 0.0006
240 HYPERREFLEXIA 2 0.0006
241 INFUSION SITE DISCHARGE 1 0.0006
242 PAPULE 4 0.0006
243 GASTROINTESTINAL OEDEMA 1 0.0006
244 HAEMORRHAGE SUBCUTANEOUS 2 0.0006
245 JUGULAR VEIN THROMBOSIS 1 0.0006
246 JOINT ARTHROPLASTY 1 0.0006
247 NO ADVERSE EFFECT 1 0.0006
248 IMMUNE-MEDIATED ENTEROCOLITIS 2 0.0005
249 CATHETER PLACEMENT 1 0.0005
250 ERYTHEMA MULTIFORME 5 0.0005
251 HEPATIC NECROSIS 2 0.0005
252 HUMAN HERPESVIRUS 6 INFECTION 1 0.0005
253 CATHETER SITE INFECTION 2 0.0005
254 BLOOD BICARBONATE DECREASED 1 0.0005
255 HYPOPROTEINAEMIA 1 0.0005
256 GRANULOCYTOPENIA 3 0.0005
257 THERAPEUTIC PRODUCT INEFFECTIVE 2 0.0005
258 OCULAR HYPERTENSION 1 0.0005
259 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 4 0.0005
260 IMMUNE-MEDIATED HEPATIC DISORDER 1 0.0005
261 ALTERED STATE OF CONSCIOUSNESS 11 0.0005
262 EMPYEMA 1 0.0005
263 ADRENAL INSUFFICIENCY 6 0.0005
264 MUSCLE CONTRACTURE 1 0.0005
265 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 1 0.0005
266 IMMUNE-MEDIATED HEPATITIS 1 0.0005
267 CHOLANGITIS SCLEROSING 1 0.0005
268 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
269 DIVERTICULAR PERFORATION 1 0.0005
270 LATENT TUBERCULOSIS 1 0.0005
271 ATRIAL TACHYCARDIA 1 0.0005
272 FACE OEDEMA 8 0.0005
273 FOETAL DISTRESS SYNDROME 1 0.0005
274 AORTIC VALVE INCOMPETENCE 2 0.0005
275 ANAEMIA MACROCYTIC 1 0.0005
276 ACUTE MYELOID LEUKAEMIA RECURRENT 1 0.0005
277 HYPOGAMMAGLOBULINAEMIA 3 0.0005
278 GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0005
279 CLOSTRIDIUM TEST POSITIVE 1 0.0005
280 CARDIAC FAILURE ACUTE 3 0.0004
281 FAECES PALE 1 0.0004
282 ILEUS PARALYTIC 2 0.0004
283 DIVERTICULUM INTESTINAL HAEMORRHAGIC 1 0.0004
284 GASTROINTESTINAL HYPOMOTILITY 1 0.0004
285 GASTRIC POLYPS 1 0.0004
286 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
287 PNEUMONIA ASPIRATION 11 0.0004
288 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
289 DERMATITIS CONTACT 5 0.0004
290 LICHENOID KERATOSIS 1 0.0004
291 ACUTE GRAFT VERSUS HOST DISEASE 2 0.0004
292 PNEUMONIA BACTERIAL 4 0.0004
293 APHTHOUS STOMATITIS 1 0.0004
294 RIGHT VENTRICULAR FAILURE 3 0.0004
295 PULMONARY TOXICITY 3 0.0004
296 BACTERAEMIA 5 0.0004
297 CHOLECYSTITIS 5 0.0004
298 LACUNAR INFARCTION 1 0.0004
299 LYMPHADENITIS 1 0.0004
300 FAECES SOFT 3 0.0004
301 GASTROENTERITIS 6 0.0004
302 BRONCHITIS CHRONIC 1 0.0004
303 MELAENA 9 0.0004
304 EYE OEDEMA 1 0.0004
305 GAMMA-GLUTAMYLTRANSFERASE INCREASED 9 0.0004
306 STAPHYLOCOCCAL SEPSIS 2 0.0004
307 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
308 PHARYNGITIS 5 0.0004
309 HYPERNATRAEMIA 2 0.0004
310 HYPERPARATHYROIDISM SECONDARY 1 0.0004
311 BRAIN ABSCESS 1 0.0004
312 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
313 TOXIC ENCEPHALOPATHY 2 0.0004
314 DERMATOMYOSITIS 1 0.0004
315 HAEMORRHAGE URINARY TRACT 1 0.0004
316 INTERSTITIAL LUNG DISEASE 19 0.0004
317 CANCER PAIN 1 0.0004
318 DISSEMINATED TUBERCULOSIS 1 0.0004
319 DEVICE RELATED INFECTION 6 0.0004
320 MEAN CELL VOLUME INCREASED 1 0.0004
321 HEPATOSPLENOMEGALY 1 0.0004
322 C-REACTIVE PROTEIN INCREASED 14 0.0004
323 LIVER DISORDER 17 0.0004
324 POLYARTHRITIS 2 0.0004
325 BLOOD POTASSIUM ABNORMAL 1 0.0004
326 AREFLEXIA 1 0.0004
327 BRUXISM 2 0.0004
328 LARGE INTESTINAL ULCER 1 0.0004
329 DECUBITUS ULCER 3 0.0004
330 ON AND OFF PHENOMENON 2 0.0004
331 VENTRICULAR FIBRILLATION 4 0.0004
332 MALNUTRITION 4 0.0004
333 DISSEMINATED INTRAVASCULAR COAGULATION 5 0.0004
334 DEPRESSED LEVEL OF CONSCIOUSNESS 14 0.0004
335 DUODENAL ULCER HAEMORRHAGE 1 0.0003
336 SUBDURAL HAEMATOMA 5 0.0003
337 HYPERTONIC BLADDER 1 0.0003
338 METASTASES TO LUNG 4 0.0003
339 PYELONEPHRITIS 3 0.0003
340 EYELID MARGIN CRUSTING 1 0.0003
341 ADENOVIRUS INFECTION 1 0.0003
342 GASTROINTESTINAL NECROSIS 1 0.0003
343 PERIPHERAL SENSORY NEUROPATHY 2 0.0003
344 THIRST 6 0.0003
345 HYPERCAPNIA 1 0.0003
346 TOXIC EPIDERMAL NECROLYSIS 5 0.0003
347 EYE INJURY 1 0.0003
348 KERATITIS 1 0.0003
349 INGUINAL HERNIA 2 0.0003
350 DYSCHEZIA 1 0.0003
351 MEDICAL DEVICE DISCOMFORT 1 0.0003
352 DYSAESTHESIA 1 0.0003
353 MENISCUS INJURY 2 0.0003
354 IRON DEFICIENCY ANAEMIA 3 0.0003
355 INFUSION SITE PRURITUS 1 0.0003
356 HEPATITIS B REACTIVATION 1 0.0003
357 STEVENS-JOHNSON SYNDROME 7 0.0003
358 INTRAOCULAR PRESSURE INCREASED 4 0.0003
359 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
360 BLOOD CREATINE PHOSPHOKINASE INCREASED 9 0.0003
361 CUSHINGOID 1 0.0003
362 ANOREXIA 4 0.0003
363 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0003
364 HERPES SIMPLEX 2 0.0003
365 OEDEMA MOUTH 1 0.0003
366 INJECTION SITE INFECTION 1 0.0003
367 INFUSION SITE HAEMORRHAGE 1 0.0003
368 LISTLESS 1 0.0003
369 CORONAVIRUS INFECTION 2 0.0003
370 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
371 ASPARTATE AMINOTRANSFERASE INCREASED 16 0.0003
372 CYTOMEGALOVIRUS INFECTION 5 0.0003
373 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
374 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
375 BLOOD UREA INCREASED 5 0.0003
376 BREAST MASS 2 0.0003
377 COLITIS ISCHAEMIC 2 0.0003
378 SUBARACHNOID HAEMORRHAGE 3 0.0003
379 HEPATIC CYST 1 0.0003
380 PNEUMONITIS 8 0.0003
381 NEUTROPHIL COUNT INCREASED 3 0.0003
382 EAR DISCOMFORT 3 0.0003
383 BRONCHOPNEUMONIA 1 0.0003
384 APLASIA PURE RED CELL 1 0.0003
385 ENCEPHALITIS 2 0.0003
386 GRANULOMA 1 0.0003
387 LARGE INTESTINE POLYP 2 0.0003
388 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
389 CEREBRAL INFARCTION 7 0.0003
390 ERYTHEMA NODOSUM 1 0.0003
391 DEPRESSIVE SYMPTOM 1 0.0003
392 JAUNDICE CHOLESTATIC 1 0.0003
393 DEVICE PLACEMENT ISSUE 1 0.0003
394 ALANINE AMINOTRANSFERASE INCREASED 17 0.0003
395 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
396 RASH PUSTULAR 2 0.0003
397 INTENTIONAL UNDERDOSE 2 0.0003
398 BLOOD PHOSPHORUS DECREASED 1 0.0003
399 AMYLASE INCREASED 1 0.0003
400 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
401 CARDIOMYOPATHY 4 0.0003
402 HYPOPHOSPHATAEMIA 2 0.0003
403 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
404 NEUTROPHIL COUNT DECREASED 11 0.0003
405 LEUKOENCEPHALOPATHY 1 0.0003
406 BLOOD SODIUM DECREASED 5 0.0003
407 CHEMOTHERAPY 1 0.0003
408 MYOCARDIAL ISCHAEMIA 3 0.0003
409 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
410 COMMUNICATION DISORDER 1 0.0003
411 LIPASE INCREASED 2 0.0003
412 RENAL FAILURE CHRONIC 2 0.0003
413 FAECES HARD 1 0.0003
414 HYPERKALAEMIA 9 0.0003
415 EPIGASTRIC DISCOMFORT 1 0.0003
416 COVID-19 PNEUMONIA 3 0.0003
417 PLATELET COUNT DECREASED 27 0.0003
418 SINUS DISORDER 5 0.0003
419 RENAL CYST 2 0.0003
420 PRESCRIBED UNDERDOSE 5 0.0003
421 AZOTAEMIA 1 0.0003
422 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
423 BLEPHARITIS 1 0.0002
424 CANDIDIASIS 1 0.0002
425 MUSCLE HAEMORRHAGE 1 0.0002
426 CARDIAC FAILURE 20 0.0002
427 ORGAN FAILURE 1 0.0002
428 CYSTITIS HAEMORRHAGIC 1 0.0002
429 STOMATITIS 15 0.0002
430 SHOCK HAEMORRHAGIC 2 0.0002
431 POLYURIA 2 0.0002
432 HICCUPS 2 0.0002
433 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
434 AORTIC DISSECTION 1 0.0002
435 PERITONITIS 5 0.0002
436 ILEUS 3 0.0002
437 FEBRILE NEUTROPENIA 16 0.0002
438 HAEMODIALYSIS 2 0.0002
439 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
440 CARDIAC FAILURE CHRONIC 1 0.0002
441 ABNORMAL SENSATION IN EYE 1 0.0002
442 MONOPLEGIA 1 0.0002
443 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
444 URINE OUTPUT DECREASED 2 0.0002
445 DIVERTICULUM INTESTINAL 1 0.0002
446 LIGAMENT RUPTURE 1 0.0002
447 LYMPHOCYTE COUNT DECREASED 4 0.0002
448 ABDOMINAL ABSCESS 1 0.0002
449 PURPURA 2 0.0002
450 BLOOD PRESSURE DECREASED 15 0.0002
451 CATHETERISATION CARDIAC 1 0.0002
452 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
453 QUALITY OF LIFE DECREASED 3 0.0002
454 MENINGITIS ASEPTIC 1 0.0002
455 BLOOD BILIRUBIN INCREASED 6 0.0002
456 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
457 HAEMOGLOBIN INCREASED 1 0.0002
458 HYPOTHYROIDISM 7 0.0002
459 IMMUNE THROMBOCYTOPENIA 1 0.0002
460 EYE OPERATION 1 0.0002
461 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
462 CONJUNCTIVITIS 4 0.0002
463 PANCYTOPENIA 12 0.0002
464 APPENDICITIS 2 0.0002
465 PLEURAL EFFUSION 13 0.0002
466 DEVICE OCCLUSION 3 0.0002
467 HYPOVOLAEMIC SHOCK 1 0.0002
468 NON-SMALL CELL LUNG CANCER 1 0.0002
469 CHOLESTASIS 4 0.0002
470 APHAGIA 1 0.0002
471 DECREASED APPETITE 48 0.0002
472 DIZZINESS POSTURAL 2 0.0002
473 AUTOIMMUNE DISORDER 2 0.0002
474 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
475 HYPERVOLAEMIA 1 0.0002
476 DIABETIC NEUROPATHY 1 0.0002
477 MUCOUS STOOLS 1 0.0002
478 HAEMATOCRIT DECREASED 4 0.0002
479 INJECTION SITE INFLAMMATION 1 0.0002
480 PREGNANCY 4 0.0002
481 ANAEMIA 38 0.0002
482 ERYSIPELAS 1 0.0002
483 CORONARY ARTERY STENOSIS 1 0.0002
484 PERITONITIS BACTERIAL 2 0.0002
485 MOTOR DYSFUNCTION 2 0.0002
486 PHARYNGEAL OEDEMA 3 0.0002
487 ENDOCARDITIS 1 0.0002
488 INITIAL INSOMNIA 2 0.0002
489 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
490 RIB FRACTURE 4 0.0002
491 CACHEXIA 1 0.0002
492 CEREBRAL ISCHAEMIA 1 0.0002
493 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
494 MUSCULOSKELETAL CHEST PAIN 3 0.0002
495 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
496 APLASTIC ANAEMIA 1 0.0002
497 RENAL IMPAIRMENT 16 0.0002
498 PNEUMOTHORAX 3 0.0002
499 SUDDEN DEATH 2 0.0002
500 LIVER FUNCTION TEST INCREASED 4 0.0002
501 GINGIVITIS 1 0.0002
502 PYREXIA 64 0.0002
503 ASPIRATION 2 0.0002
504 VENTRICULAR TACHYCARDIA 3 0.0002
505 AUTISM SPECTRUM DISORDER 1 0.0002
506 VISUAL ACUITY REDUCED 6 0.0002
507 GASTRIC ULCER HAEMORRHAGE 1 0.0002
508 SKIN DISORDER 6 0.0002
509 SEPSIS 20 0.0002
510 INTESTINAL PERFORATION 2 0.0002
511 ACUTE PULMONARY OEDEMA 1 0.0002
512 BLOOD CALCIUM DECREASED 2 0.0002
513 HYPONATRAEMIA 10 0.0002
514 STATUS EPILEPTICUS 2 0.0002
515 MITRAL VALVE INCOMPETENCE 2 0.0002
516 CHOLECYSTITIS ACUTE 1 0.0002
517 GENERALISED ERYTHEMA 1 0.0002
518 MICTURITION URGENCY 2 0.0002
519 GASTRIC HAEMORRHAGE 2 0.0002
520 MADAROSIS 2 0.0002
521 HYPERTRIGLYCERIDAEMIA 1 0.0002
522 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
523 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
524 BLOOD CREATININE INCREASED 11 0.0002
525 RHABDOMYOLYSIS 7 0.0002
526 PRODUCTIVE COUGH 8 0.0002
527 MUSCLE RIGIDITY 2 0.0002
528 ELECTROCARDIOGRAM QT PROLONGED 6 0.0002
529 GANGRENE 1 0.0002
530 TOOTHACHE 3 0.0002
531 NEURALGIA 4 0.0002
532 RESPIRATORY DEPRESSION 2 0.0002
533 BRONCHITIS 12 0.0002
534 OLIGURIA 1 0.0002
535 PHOTOPHOBIA 3 0.0002
536 BLEPHAROSPASM 1 0.0002
537 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
538 GASTRIC CANCER 4 0.0002
539 PROTEINURIA 3 0.0002
540 FOREIGN BODY SENSATION IN EYES 1 0.0002
541 HERPES ZOSTER 9 0.0002
542 GALACTORRHOEA 1 0.0002
543 ANAPHYLACTIC SHOCK 4 0.0002
544 DRUG SPECIFIC ANTIBODY PRESENT 1 0.0002
545 RESPIRATORY TRACT INFECTION 4 0.0002
546 PLATELET COUNT INCREASED 2 0.0002
547 ORAL CANDIDIASIS 2 0.0002
548 STAPHYLOCOCCAL INFECTION 5 0.0002
549 ASTHMA 17 0.0002
550 MENINGITIS 1 0.0001
551 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
552 PNEUMONIA 48 0.0001
553 TASTE DISORDER 3 0.0001
554 WHITE BLOOD CELL COUNT DECREASED 16 0.0001
555 OEDEMA 8 0.0001
556 GINGIVAL BLEEDING 2 0.0001
557 EYE MOVEMENT DISORDER 1 0.0001
558 CROHN'S DISEASE 1 0.0001
559 JOINT EFFUSION 1 0.0001
560 DIVERTICULITIS 4 0.0001
561 PULMONARY HYPERTENSION 3 0.0001
562 AUTOIMMUNE HEPATITIS 1 0.0001
563 DERMATITIS 3 0.0001
564 CARDIOGENIC SHOCK 2 0.0001
565 DERMATITIS BULLOUS 1 0.0001
566 SEPTIC SHOCK 6 0.0001
567 HYPERGLYCAEMIA 5 0.0001
568 MOUTH HAEMORRHAGE 1 0.0001
569 ORAL PAIN 3 0.0001
570 ECONOMIC PROBLEM 2 0.0001
571 HEPATOCELLULAR CARCINOMA 1 0.0001
572 HAEMODYNAMIC INSTABILITY 1 0.0001
573 HYPERTHERMIA 1 0.0001
574 EPILEPSY 4 0.0001
575 INSURANCE ISSUE 2 0.0001
576 SHOCK 3 0.0001
577 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
578 PERICARDIAL EFFUSION 3 0.0001
579 ATRIOVENTRICULAR BLOCK 1 0.0001
580 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
581 HYPOALBUMINAEMIA 1 0.0001
582 NICOTINE DEPENDENCE 1 0.0001
583 SWOLLEN TONGUE 4 0.0001
584 DRUG-INDUCED LIVER INJURY 4 0.0001
585 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
586 ARRHYTHMIA 6 0.0001
587 ANAPHYLACTIC REACTION 7 0.0001
588 ERYTHEMA 26 0.0001
589 ABNORMAL BEHAVIOUR 5 0.0001
590 DISORIENTATION 5 0.0001
591 BLOOD ALBUMIN DECREASED 1 0.0001
592 ATRIAL FLUTTER 1 0.0001
593 NEUTROPENIA 17 0.0001
594 BLOOD POTASSIUM INCREASED 2 0.0001
595 ASPHYXIA 1 0.0001
596 MENSTRUAL DISORDER 1 0.0001
597 ACUTE CORONARY SYNDROME 1 0.0001
598 FUNGAL INFECTION 4 0.0001
599 URINARY RETENTION 4 0.0001
600 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
601 HYPOPHAGIA 3 0.0001
602 DELIRIUM 4 0.0001
603 NAIL DISORDER 1 0.0001
604 EOSINOPHILIA 2 0.0001
605 GRIP STRENGTH DECREASED 1 0.0001
606 IMMUNOSUPPRESSION 1 0.0001
607 LUNG INFILTRATION 1 0.0001
608 LYMPHADENOPATHY 4 0.0001
609 CEREBRAL HAEMORRHAGE 4 0.0001
610 PULMONARY OEDEMA 5 0.0001
611 HAEMOLYTIC ANAEMIA 1 0.0001
612 HAEMARTHROSIS 1 0.0001
613 MYOSITIS 1 0.0001
614 ANAL INCONTINENCE 1 0.0001
615 DEVELOPMENTAL DELAY 1 0.0001
616 GASTROENTERITIS VIRAL 2 0.0001
617 OROPHARYNGEAL DISCOMFORT 1 0.0001
618 LUPUS-LIKE SYNDROME 1 0.0001
619 OPTIC NEURITIS 1 0.0001
620 HIDRADENITIS 1 0.0001
621 SKIN LESION 3 0.0001
622 HAEMATOCHEZIA 6 0.0001
623 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
624 HYPOKALAEMIA 5 0.0001
625 HAEMOPTYSIS 3 0.0001
626 RENAL DISORDER 5 0.0001
627 HEPATIC ENCEPHALOPATHY 1 0.0001
628 HAEMOGLOBIN DECREASED 11 0.0001
629 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
630 OEDEMA PERIPHERAL 13 0.0001
631 DYSARTHRIA 4 0.0001
632 ABORTION INDUCED 1 0.0001
633 INTESTINAL OBSTRUCTION 4 0.0001
634 LEUKAEMIA 1 0.0001
635 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
636 HYPOCALCAEMIA 2 0.0001
637 INFUSION RELATED REACTION 7 0.0001
638 FOOT FRACTURE 2 0.0001
639 OCULAR HYPERAEMIA 5 0.0001
640 SLEEP APNOEA SYNDROME 2 0.0001
641 ANGINA PECTORIS 3 0.0001
642 INCREASED APPETITE 2 0.0001
643 ACUTE RESPIRATORY FAILURE 2 0.0001
644 HYPERCHOLESTEROLAEMIA 1 0.0001
645 ATELECTASIS 1 0.0001
646 DYSSTASIA 3 0.0001
647 HAEMORRHOIDS 2 0.0001
648 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
649 HOSPICE CARE 1 0.0001
650 LIGAMENT SPRAIN 1 0.0001
651 BLOOD PRESSURE ABNORMAL 2 0.0001
652 DRY EYE 5 0.0001
653 CYTOKINE RELEASE SYNDROME 2 0.0001
654 LACRIMATION INCREASED 3 0.0001
655 CELLULITIS 5 0.0001
656 HYPOTHERMIA 1 0.0001
657 FEEDING DISORDER 2 0.0001
658 DYSKINESIA 4 0.0001
659 BONE MARROW FAILURE 2 0.0001
660 FLUID RETENTION 5 0.0001
661 DRUG LEVEL DECREASED 1 0.0001
662 EUPHORIC MOOD 1 0.0001
663 INJECTION SITE WARMTH 2 0.0001
664 EYE DISCHARGE 1 0.0001
665 POLLAKIURIA 4 0.0001
666 MUSCULOSKELETAL PAIN 5 0.0001
667 INCONTINENCE 1 0.0001
668 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
669 LOSS OF CONSCIOUSNESS 12 0.0001
670 DECREASED ACTIVITY 1 0.0001
671 FAECES DISCOLOURED 2 0.0001
672 RASH 40 0.0001
673 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
674 TREATMENT NONCOMPLIANCE 5 0.0001
675 IMPAIRED HEALING 3 0.0001
676 EYE PRURITUS 3 0.0001
677 OCULAR DISCOMFORT 1 0.0001
678 PANCREATITIS ACUTE 2 0.0001
679 EYE INFECTION 1 0.0001
680 INTERNAL HAEMORRHAGE 1 0.0001
681 MYOCARDITIS 1 0.0001
682 EYE IRRITATION 5 0.0001
683 EYELID OEDEMA 1 0.0001
684 CAESAREAN SECTION 1 0.0001
685 HYPOXIA 3 0.0001
686 NEUROLEPTIC MALIGNANT SYNDROME 1 0.0001
687 DISEASE RECURRENCE 4 0.0001
688 MYOCLONUS 1 0.0001
689 INFECTION 12 0.0001
690 DRUG EFFECT INCOMPLETE 3 0.0001
691 HYPOGLYCAEMIA 4 0.0001
692 NOCTURIA 1 0.0001
693 MALAISE 36 0.0001
694 INJECTION SITE URTICARIA 2 0.0001
695 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
696 CARDIOMEGALY 1 0.0001
697 GENERALISED OEDEMA 1 0.0001
698 INFLUENZA 9 0.0001
699 CYST 1 0.0001
700 EPISTAXIS 6 0.0001
701 DYSPNOEA EXERTIONAL 3 0.0001
702 DERMATITIS ALLERGIC 1 0.0001
703 HAEMATEMESIS 2 0.0001
704 INJECTION SITE IRRITATION 1 0.0001
705 GASTROINTESTINAL DISORDER 7 0.0001
706 INFUSION SITE PAIN 1 0.0001
707 ABDOMINAL PAIN 18 0.0001
708 INJECTION SITE INDURATION 1 0.0001
709 ANHEDONIA 2 0.0001
710 DIARRHOEA 49 0.0001
711 JOINT RANGE OF MOTION DECREASED 1 0.0001
712 JAUNDICE 2 0.0001
713 PALLOR 2 0.0001
714 DRUG TOXICITY 1 0.0001
715 CONSTIPATION 16 0.0001
716 ACUTE HEPATIC FAILURE 1 0.0001
717 OSTEOPOROSIS 3 0.0001
718 PROCEDURAL PAIN 2 0.0001
719 HYPOMAGNESAEMIA 1 0.0001
720 CARDIO-RESPIRATORY ARREST 3 0.0001
721 COORDINATION ABNORMAL 1 0.0001
722 APHONIA 1 0.0001
723 LYMPHOPENIA 1 0.0001
724 RENAL FAILURE ACUTE 3 0.0001
725 DIALYSIS 1 0.0001
726 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
727 RED BLOOD CELL COUNT DECREASED 2 0.0001
728 IMPAIRED QUALITY OF LIFE 1 0.0001
729 HYPERTHYROIDISM 1 0.0001
730 URINARY INCONTINENCE 2 0.0001
731 MATERNAL EXPOSURE DURING PREGNANCY 6 0.0001
732 COLON CANCER 1 0.0001
733 HAEMORRHAGE INTRACRANIAL 1 0.0001
734 RESPIRATORY DISORDER 2 0.0001
735 HYPOAESTHESIA 10 0.0001
736 BONE LOSS 1 0.0001
737 HALLUCINATION 5 0.0001
738 HEPATIC FAILURE 2 0.0001
739 HYPOAESTHESIA ORAL 1 0.0001
740 OSTEOPENIA 1 0.0001
741 TINNITUS 3 0.0001
742 LIMB DISCOMFORT 2 0.0001
743 ANKLE FRACTURE 1 0.0001
744 LUNG INFECTION 1 0.0001
745 EJECTION FRACTION DECREASED 1 0.0001
746 ACUTE MYELOID LEUKAEMIA 1 0.0001
747 NERVOUS SYSTEM DISORDER 2 0.0001
748 MENINGIOMA 1 0.0001
749 CYANOSIS 1 0.0001
750 HEAD INJURY 2 0.0001
751 HALLUCINATION, AUDITORY 1 0.0001
752 CYSTITIS 2 0.0001
753 OBESITY 1 0.0001
754 THROMBOSIS 5 0.0001
755 METASTASES TO BONE 1 0.0001
756 MANIA 1 0.0001
757 DRUG LEVEL INCREASED 1 0.0001
758 VIRAL INFECTION 2 0.0001
759 COAGULOPATHY 1 0.0001
760 LEUKOPENIA 3 0.0001
761 DEHYDRATION 8 0.0001
762 GASTROINTESTINAL HAEMORRHAGE 5 0.0001
763 PALPITATIONS 7 0.0001
764 URTICARIA 10 0.0001
765 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
766 HYPERSENSITIVITY 11 0.0001
767 CANDIDA INFECTION 1 0.0001
768 CIRCULATORY COLLAPSE 1 0.0001
769 PRODUCT USE ISSUE 11 0.0001
770 HAEMATURIA 2 0.0001
771 VISION BLURRED 8 0.0001
772 INFLAMMATION 3 0.0001
773 MUSCULOSKELETAL DISCOMFORT 1 0.0001
774 NEOPLASM PROGRESSION 2 0.0001
775 ECZEMA 3 0.0001
776 LOCAL SWELLING 1 0.0001
777 NEUROTOXICITY 1 0.0001
778 COLD SWEAT 1 0.0001
779 DRUG INTERACTION 9 0.0001
780 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
781 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
782 HEAD DISCOMFORT 1 0.0001
783 ISCHAEMIC STROKE 1 0.0001
784 GALLBLADDER DISORDER 1 0.0001
785 GOUT 1 0.0001
786 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10 0.0001
787 OSTEOMYELITIS 1 0.0001
788 BONE DISORDER 1 0.0001
789 RESPIRATORY FAILURE 4 0.0001
790 END STAGE RENAL DISEASE 1 0.0001
791 RESTLESSNESS 2 0.0001
792 BLOOD GLUCOSE ABNORMAL 1 0.0001
793 AGRANULOCYTOSIS 1 0.0001
794 EYE SWELLING 2 0.0001
795 HEPATIC STEATOSIS 1 0.0001
796 NECK PAIN 3 0.0001
797 BACTERIAL INFECTION 1 0.0001
798 MIDDLE INSOMNIA 1 0.0001
799 HEPATIC CIRRHOSIS 1 0.0001
800 EYE PAIN 3 0.0001
801 FRACTURE 1 0.0001
802 MUSCULAR WEAKNESS 6 0.0001
803 COLITIS 2 0.0001
804 NEUROPATHY PERIPHERAL 5 0.0001
805 CONVULSION 3 0.0001
806 LOWER LIMB FRACTURE 1 0.0001
807 DRUG PRESCRIBING ERROR 1 0.0001
808 GLAUCOMA 1 0.0001
809 EAR PAIN 1 0.0001
810 DYSPHONIA 3 0.0001
811 PLASMA CELL MYELOMA 2 0.0001
812 ORAL HERPES 1 0.0001
813 WHEEZING 3 0.0001
814 DISABILITY 1 0.0001
815 CATARACT 3 0.0001
816 CARDIAC FAILURE CONGESTIVE 4 0.0000
817 THERAPEUTIC RESPONSE DECREASED 3 0.0000
818 SUICIDE ATTEMPT 3 0.0000
819 CONDITION AGGRAVATED 15 0.0000
820 INJURY ASSOCIATED WITH DEVICE 1 0.0000
821 BODY TEMPERATURE INCREASED 1 0.0000
822 NASOPHARYNGITIS 9 0.0000
823 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
824 LUNG NEOPLASM MALIGNANT 2 0.0000
825 HALLUCINATION, VISUAL 1 0.0000
826 BACK PAIN 11 0.0000
827 PRURITUS 18 0.0000
828 INTENTIONAL OVERDOSE 3 0.0000
829 RHINORRHOEA 3 0.0000
830 COUGH 13 0.0000
831 DEEP VEIN THROMBOSIS 3 0.0000
832 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
833 MENTAL DISORDER 2 0.0000
834 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
835 ACUTE KIDNEY INJURY 7 0.0000
836 COLITIS ULCERATIVE 2 0.0000
837 VOMITING 21 0.0000
838 CHROMATURIA 1 0.0000
839 NEPHROLITHIASIS 2 0.0000
840 DISEASE PROGRESSION 5 0.0000
841 OFF LABEL USE 37 0.0000
842 DYSPHAGIA 4 0.0000
843 RASH ERYTHEMATOUS 2 0.0000
844 GAIT DISTURBANCE 8 0.0000
845 DRUG INEFFECTIVE 55 0.0000
846 OVERDOSE 9 0.0000
847 BLOOD PRESSURE FLUCTUATION 1 0.0000
848 BLOOD GLUCOSE DECREASED 2 0.0000
849 DIABETIC KETOACIDOSIS 1 0.0000
850 HEPATIC CANCER 1 0.0000
851 LOCALISED INFECTION 1 0.0000
852 EMOTIONAL DISTRESS 5 0.0000
853 INSOMNIA 11 0.0000
854 MYALGIA 7 0.0000
855 URINARY TRACT INFECTION 7 0.0000
856 LUNG DISORDER 2 0.0000
857 ENCEPHALOPATHY 1 0.0000
858 ABASIA 1 0.0000
859 OSTEONECROSIS OF JAW 1 0.0000
860 EXTRAPYRAMIDAL DISORDER 1 0.0000
861 WEIGHT INCREASED 9 0.0000
862 ACNE 3 0.0000
863 CHRONIC KIDNEY DISEASE 3 0.0000
864 CARDIOVASCULAR DISORDER 1 0.0000
865 DIABETES MELLITUS 3 0.0000
866 HEPATITIS 1 0.0000
867 FALL 13 0.0000
868 DRUG RESISTANCE 1 0.0000
869 DYSPNOEA 22 0.0000
870 DIPLOPIA 1 0.0000
871 ARTHRALGIA 16 0.0000
872 SPEECH DISORDER 2 0.0000
873 GASTRITIS 1 0.0000
874 DERMATITIS ATOPIC 2 0.0000
875 NAUSEA 30 0.0000
876 CHEST PAIN 7 0.0000
877 HYPERTENSION 8 0.0000
878 DRY SKIN 5 0.0000
879 PROSTATE CANCER 3 0.0000
880 FEELING COLD 1 0.0000
881 DEMENTIA 1 0.0000
882 THROMBOCYTOPENIA 4 0.0000
883 BLISTER 2 0.0000
884 OXYGEN SATURATION DECREASED 2 0.0000
885 FLATULENCE 2 0.0000
886 RHEUMATOID ARTHRITIS 4 0.0000
887 HYPERSOMNIA 1 0.0000
888 PANCREATIC CARCINOMA 1 0.0000
889 LIVER FUNCTION TEST ABNORMAL 1 0.0000
890 CHILLS 4 0.0000
891 ASCITES 1 0.0000
892 BLADDER CANCER 2 0.0000
893 TACHYCARDIA 3 0.0000
894 BLOOD POTASSIUM DECREASED 1 0.0000
895 DISCOMFORT 2 0.0000
896 BLOOD PRESSURE INCREASED 5 0.0000
897 DRUG ADMINISTRATION ERROR 1 0.0000
898 BONE DENSITY DECREASED 1 0.0000
899 METABOLIC ACIDOSIS 1 0.0000
900 MOVEMENT DISORDER 1 0.0000
901 LACTIC ACIDOSIS 1 0.0000
902 ATRIAL FIBRILLATION 3 0.0000
903 AMNESIA 2 0.0000
904 SWELLING FACE 2 0.0000
905 ALOPECIA 6 0.0000
906 DYSPEPSIA 3 0.0000
907 OSTEONECROSIS 1 0.0000
908 EYE DISORDER 1 0.0000
909 RENAL FAILURE 4 0.0000
910 SOMNOLENCE 6 0.0000
911 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
912 SINUSITIS 3 0.0000
913 ILLNESS 3 0.0000
914 HEART RATE DECREASED 1 0.0000
915 MOBILITY DECREASED 2 0.0000
916 MYELOSUPPRESSION 1 0.0000
917 UNDERDOSE 2 0.0000
918 ACCIDENTAL OVERDOSE 1 0.0000
919 DYSURIA 1 0.0000
920 DYSGEUSIA 2 0.0000
921 INJECTION SITE SWELLING 2 0.0000
922 DIZZINESS 12 0.0000
923 ASTHENIA 9 0.0000
924 ABDOMINAL DISCOMFORT 4 0.0000
925 PAIN IN EXTREMITY 7 0.0000
926 HYPERHIDROSIS 3 0.0000
927 DEVICE DISLOCATION 1 0.0000
928 INTENTIONAL PRODUCT MISUSE 2 0.0000
929 HEADACHE 14 0.0000
930 DEVICE ISSUE 2 0.0000
931 MUSCLE SPASMS 4 0.0000
932 OROPHARYNGEAL PAIN 2 0.0000
933 WEIGHT DECREASED 6 0.0000
934 BLOOD CHOLESTEROL INCREASED 1 0.0000
935 BLOOD GLUCOSE INCREASED 4 0.0000
936 PULMONARY EMBOLISM 2 0.0000
937 CONTUSION 2 0.0000
938 PRODUCT DOSE OMISSION ISSUE 6 0.0000
939 SYNCOPE 2 0.0000
940 HYPOTENSION 4 0.0000
941 PAIN 12 0.0000
942 CHEST DISCOMFORT 2 0.0000
943 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
944 ABDOMINAL DISTENSION 2 0.0000
945 NERVOUSNESS 1 0.0000
946 HAEMORRHAGE 2 0.0000
947 PARAESTHESIA 3 0.0000
948 DEPRESSED MOOD 1 0.0000
949 DRUG EFFECT DECREASED 1 0.0000
950 DISTURBANCE IN ATTENTION 1 0.0000
951 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
952 ARTHROPATHY 1 0.0000
953 MEDICATION ERROR 1 0.0000
954 TOXICITY TO VARIOUS AGENTS 3 0.0000
955 ANXIETY 5 0.0000
956 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
957 COVID-19 3 0.0000
958 BONE PAIN 1 0.0000
959 NASAL CONGESTION 1 0.0000
960 FATIGUE 13 0.0000
961 FEELING ABNORMAL 4 0.0000
962 IRRITABILITY 1 0.0000
963 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
964 INJECTION SITE ERYTHEMA 2 0.0000
965 EXPOSURE DURING PREGNANCY 1 0.0000
966 DEATH 13 0.0000
967 NEOPLASM MALIGNANT 1 0.0000
968 INJECTION SITE PRURITUS 1 0.0000
969 HEPATIC ENZYME INCREASED 1 0.0000
970 ABDOMINAL PAIN UPPER 3 0.0000
971 INJURY 1 0.0000
972 HOT FLUSH 1 0.0000
973 DEPRESSION 3 0.0000
974 INCORRECT DOSE ADMINISTERED 3 0.0000
975 ARTHRITIS 1 0.0000
976 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
977 INFLUENZA LIKE ILLNESS 1 0.0000
978 CARDIAC ARREST 1 0.0000
979 TREMOR 2 0.0000
980 MYOCARDIAL INFARCTION 2 0.0000
981 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
982 ADVERSE DRUG REACTION 1 0.0000
983 ADVERSE EVENT 1 0.0000
984 BREAST CANCER 1 0.0000
985 FLUSHING 1 0.0000
986 INJECTION SITE PAIN 3 0.0000
987 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
988 JOINT SWELLING 1 0.0000
989 MEMORY IMPAIRMENT 1 0.0000
990 CEREBROVASCULAR ACCIDENT 1 0.0000
991 NO ADVERSE EVENT 1 0.0000